22468 Results

People

  1. Ladanyi
    Ladanyi
  2. Antonescu
    Antonescu
  3. Offit
    Offit
  4. Solit
    Solit
  5. Levine
    Levine
  6. Berger
    Berger
  7. O'Reilly
    O'Reilly
  8. Cheung
    Cheung
  9. Reis-Filho
    Reis-Filho
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)
  7. Human Oncology and Pathogenesis Program (5697)
  8. Center for Hematologic Malignancies (5359)
  9. Center for Molecular Imaging and Biotechnology (5298)
  10. Department of Pathology and Laboratory Medicine (4773)
  1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A risk-adapted study to assess the efficacy of enasidenib and subsequent response-driven addition of azacitidine for newly diagnosed IDH2-mutant AML patients: 3-year follow-up
    Meeting Abstract

    Stein, E.; Cai, S. F.; Huang, Y.; Dunbar, A.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Schiller, G. J.; Olin, R. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders
    Meeting Abstract

    Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination
    Meeting Abstract

    GutieĢrrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of epichaperome inhibitor PU-H71 on anti-tumor T cell responses and its implications for immune and cellular therapy
    Meeting Abstract

    Martinet, J.; Sugita, M.; Alhomoud, M.; Abad, C.; Chiosis, G.; Roboz, G. J.; Boyer, O.; Guzman, M. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Combined genetic ablation of CD54 and CD58 in car engineered cytotoxic lymphocytes effectively averts allogeneic immune cell rejection
    Meeting Abstract

    Hammer, Q.; Perica, K.; Mbofung, R. M.; van Ooijen, H.; Varady, E.; Jelcic, M.; Pan, Y.; Momayyezi, P.; Groff, B.; Abujarour, R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Attenuation of graft-versus-host-disease via genetic or pharmacologic inhibition of the RNA splicing factor RBM39
    Meeting Abstract

    Bourcier, J.; Hogg, S. J.; Erickson, C.; Singer, M. E.; Tittley, S.; Ito, T.; Egorova, A.; Kuttiyara, J.; Hanash, A. M.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Microbial bile acid metabolism shapes effector T cell responses during inflammation in mouse and human
    Meeting Abstract

    Lindner, S.; Miltiadous, O.; Ramos, R. J.; Dai, A.; Kousa, A.; Armijo, G. K.; Ghale, R.; Nguyen, C. L.; Paredes Sanchez, J.; Fei, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Donor-derived amphiregulin drives CD4(+) T cell expansion and promotes tissue pathology after experimental allogeneic BMT
    Meeting Abstract

    Ito, T.; Takashima, S.; Calafiore, M.; Fu, Y. Y.; Egorova, A.; Kuttiyara, J.; Chang, W.; Vinci, P.; Arnhold, V.; Zaiss, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Imetelstat-mediated alterations in lipid metabolism to induce ferroptosis as therapeutic strategy for acute myeloid leukemia
    Meeting Abstract

    Bruedigam, C.; Porter, A. H.; Song, A.; in de Wei, G. V.; Stoll, T.; Straube, J.; Cooper, L. T.; Cheng, G. D.; Kahl, V. F. S.; Sobinoff, A.; more...
    Blood (2022)

    Fulltext@MSK | Save